BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $273,917 | -17.2% | 7,258 | 0.0% | 0.01% | -15.4% |
Q2 2023 | $330,674 | +12.3% | 7,258 | 0.0% | 0.01% | +8.3% |
Q1 2023 | $294,384 | -22.1% | 7,258 | -2.2% | 0.01% | -20.0% |
Q4 2022 | $378,095 | -9.5% | 7,418 | -4.3% | 0.02% | -16.7% |
Q3 2022 | $418,000 | -15.7% | 7,754 | +0.5% | 0.02% | -14.3% |
Q2 2022 | $496,000 | -20.4% | 7,715 | -4.0% | 0.02% | -12.5% |
Q1 2022 | $623,000 | -2.2% | 8,040 | +8.4% | 0.02% | +4.3% |
Q4 2021 | $637,000 | +7.8% | 7,415 | +0.8% | 0.02% | -4.2% |
Q3 2021 | $591,000 | -0.2% | 7,354 | 0.0% | 0.02% | 0.0% |
Q2 2021 | $592,000 | -3.3% | 7,354 | +1.3% | 0.02% | -7.7% |
Q1 2021 | $612,000 | -2.2% | 7,258 | -6.9% | 0.03% | -7.1% |
Q4 2020 | $626,000 | -0.2% | 7,799 | 0.0% | 0.03% | -9.7% |
Q3 2020 | $627,000 | -6.6% | 7,799 | 0.0% | 0.03% | -13.9% |
Q2 2020 | $671,000 | +6.0% | 7,799 | 0.0% | 0.04% | -7.7% |
Q1 2020 | $633,000 | -2.9% | 7,799 | 0.0% | 0.04% | +18.2% |
Q4 2019 | $652,000 | -4.4% | 7,799 | 0.0% | 0.03% | -15.4% |
Q3 2019 | $682,000 | +6.7% | 7,799 | 0.0% | 0.04% | 0.0% |
Q2 2019 | $639,000 | +0.8% | 7,799 | 0.0% | 0.04% | -7.1% |
Q1 2019 | $634,000 | +18.9% | 7,799 | -3.7% | 0.04% | +2.4% |
Q4 2018 | $533,000 | +7.5% | 8,099 | +25.8% | 0.04% | +17.1% |
Q3 2018 | $496,000 | +6.0% | 6,437 | +1.6% | 0.04% | -5.4% |
Q2 2018 | $468,000 | +13.6% | 6,337 | 0.0% | 0.04% | +15.6% |
Q1 2018 | $412,000 | -2.6% | 6,337 | -3.2% | 0.03% | +6.7% |
Q4 2017 | $423,000 | +2.9% | 6,544 | 0.0% | 0.03% | 0.0% |
Q3 2017 | $411,000 | +3.8% | 6,544 | 0.0% | 0.03% | +3.4% |
Q2 2017 | $396,000 | +16.8% | 6,544 | 0.0% | 0.03% | +11.5% |
Q1 2017 | $339,000 | -88.6% | 6,544 | -91.6% | 0.03% | -90.6% |
Q4 2015 | $2,979,000 | +56.9% | 78,075 | +35.1% | 0.28% | +45.8% |
Q3 2015 | $1,899,000 | -31.9% | 57,795 | +44.9% | 0.19% | -29.4% |
Q2 2015 | $2,790,000 | +1241.3% | 39,895 | +1212.8% | 0.27% | +1394.4% |
Q1 2015 | $208,000 | -5.5% | 3,039 | +1.5% | 0.02% | -10.0% |
Q4 2014 | $220,000 | +2.3% | 2,995 | 0.0% | 0.02% | -4.8% |
Q3 2014 | $215,000 | -87.3% | 2,995 | -87.0% | 0.02% | -88.6% |
Q1 2014 | $1,695,000 | +4.3% | 23,040 | -1.4% | 0.18% | -2.6% |
Q4 2013 | $1,625,000 | -16.7% | 23,364 | -21.3% | 0.19% | -25.8% |
Q3 2013 | $1,950,000 | – | 29,690 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |